chrisvoncsefalvay/vaers-outcomes huggingface dataset:
very disoriented; neurologically and cognitively there has been a continuous decline; neurologically and cognitively there has been a continuous decline; bed confined; unable to talk; forgetful; lightheartedness; unable to sleep; diarrhea; fell; colitis; anemia; dehydration; PE in lungs; DVT right leg; Decrease level of consciousness; Could not walk without assistance; This is a spontaneous report received from a contactable consumer via a consumer (patient). A 75-year-old female patient received second dose of bnt162b2 (Batch/Lot Number: El9265), via an unspecified route of administration, administered in Arm Left on 26Feb2021 at age of 75-year-old as single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was doctor's office/ urgent care. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination. The patient previously received first dose of bnt162b2 (Batch/Lot Number: El9265), via an unspecified route of administration, administered in Arm Left on 05Feb2021 at age of 75-year-old as single dose for covid-19 immunisation. Medical history included High blood pressure, high cholesterol. No known allergies. Concomitant medications included lisinopril, ranolazine (RANEXA), simvastatin, ubidecarenone (COQ10), calcium. On Mar2021, two weeks after 2nd vaccine, the patient started being very forgetful, lightheartedness. 4 weeks following 2nd vaccine, patient was unable to sleep, diarrhea and fell on 3 different occasions. By Apr2021 became very disoriented, diarrhea continued. Was taken to emergency room and was diagnosed colitis, anemia, dehydration, pulmonary embolism (PE) in lungs and deep venous thrombosis (DVT) right leg. Patient was admitted into hospital for 3 days. Discharged 3 days later, could not walk without assistance and experience decrease level of consciousness. Hospital discharge doctor stated that Physical therapy and hydration will offer her a full recovery. Since the beginning of Apr2021 neurologically and cognitively there had been a continuous decline. Before Apr2021 patient was independent, living on her own, paying Bill's, driving, and preparing her own meals. Now she was bed confined, unable to talk. In early Jun2021, while she was still able to move via walker assistance she was referred to neurologist, MD. He performed MRI, EEG, and MR venagram. He ruled out stroke, and blood clot to brain. The patient received pednisone as treatment. The adverse events result in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Seriousness criteria were reported as life threatening, caused/ prolonged hospitalization and disabling/ incapacitating. COVID test (Nasal Swab) post vaccination on 05Apr2021 with result negative. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Pt was given immunizations on 8/11/03. Mom called office 8/13/03 stating that left leg was swollen to the size of a baseball, red and very hot. Pt came in to office for evaluation. Told to use cool compresses and massage for comfort.
Over dosage of influenza was administered, recommended dosage is .5ML. 1ML dosage was administered in error.
Six days post vax, the pt developed papulovesicular rash on erythematous base consistent with varicella.
she does not feel well; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EU9231), via an unspecified route of administration in the left arm on 05Jan2021 at a single dose for COVID-19 immunization. There were no medical history and concomitant medications. The patient does not feel well on 06Jan2021. Outcome of the event was unknown.
area is getting bigger; Warm to touch; Injected area was itching; Hardish; tenderness; Redness; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish) and VACCINATION SITE PAIN (tenderness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish), VACCINATION SITE PAIN (tenderness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling). At the time of the report, VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish), VACCINATION SITE PAIN (tenderness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: No specific follow-up information recorded.
Mom noticed a small red area where the Prevnar was given.  Mom kept an eye on it, about a week later she noticed that it was redder and had a knot under the it.  She states that it was very red and it grew larger, about an inch.  Used OTC hydrocortisone and it didn't really help that much.  Mom states that it does not hurt patient, she will move her leg without pain.
Has not received the Second Shot, more than 6 weeks since  first Moderna shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not received the Second Shot, more than 6 weeks since  first Moderna shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received the Second Shot, more than 6 weeks since  first Moderna shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Has not received the Second Shot, more than 6 weeks since  first Moderna shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  No treatment medications were reported.
Muscle soreness; swelling; Severe redness with burning and itching; Severe redness with burning and itching; Severe redness with burning and itching; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 80 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Oct2021 (Lot number: EW0185) at the age of 80 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Heart disease" (ongoing); "flu" (unspecified if ongoing), notes: Got the flu vaccine at (Name) recently, but does not know the exact date. It was more than 2 weeks before the booster. Concomitant medication(s) included: FLU VACCINE VII taken for influenza. Vaccination history included: Bnt162b2 (First Dose , Lot- EN6202 Exp: unknown, administered left upper arm, Vaccine Name: Covid Vaccine , Lot Number / Expiry Date: EN6202 Exp: unknown, Anatomical Location: administered left upper arm , Date: 04Mar2021, Vaccine Name: Covid Vaccine , Lot Number / Expiry Date: ER8730 Exp: unknown, Anatomical Location: administered left upper arm , Date: 25Mar2021), administration date: 04Mar2021, when the patient was 79 years old, for Covid-19 immunization.  The following information was reported: PRURITUS (non-serious), ERYTHEMA (non-serious), BURNING SENSATION (non-serious) all with onset 08Oct2021, outcome "recovering" and all described as "Severe redness with burning and itching"; MYALGIA (non-serious), outcome "unknown", described as "Muscle soreness"; SWELLING (non-serious) with onset 08Oct2021, outcome "recovering", described as "swelling".  Additional information: Two days later after booster dose, later confirmed as on 08Oct2021 she had had something round into the muscle and she had severe redness with extreme burning. It was burning like hell. This continued until about yesterday. She had itching with burning. It first appeared as a red spot, it was hot, and burned so bad. When probed for outcome she stated this was noticeable still. It was still a little itchy, it's not as red. There was still like a pink border where there was swelling and itching. The events did not require emergency room and physician office visit. Prior to vaccination she did not receive vaccines within 4 weeks. At end of call caller commented she did not have a fever or fatigue. She just had the burning real bad. She later added she did have some muscle soreness right after the vaccine, but the intense burning came later. She did have some nurses come look at it.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 06-MAY-2014, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J002306 and expiry date: 22-AUG-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Patient was administered dose three of Pfizer prior to the minimum interval. A repeat dose is needed after the dose given in error. Nurse attempted to contact patient's mother by phone. Message left. Nurse consultant notified and will follow up with patient's mother.
On September 23rd 2021 I got my second dose in my left arm. It hurt from the time of injection continuing on to today which is November the 9th 2021 I have had problems with pain in my left arm and in my left leg that actually hurt so bad sometimes I cannot walk when I get up from sitting. Also my left breast has been leaking a clear liquid for probably a month or so
Muscle spasms and neck stiffness, especially in trapezius muscles on shoulder. Naproxen (440mg) and icing the shoulder provided moderate relief (pain down from 8 to 4) after pain awoke me from sleep.
Almost 4 weeks after my 2nd dose, I got very bad chills followed by high fever.  I took Advil, sweated out the fever over night, and was fine the next day.  About 4-5 weeks later, the exact same thing happened!  Both times, the chills started around 8pm.  Both times, I was fine the next morning after sweating off the fever over night.   Fever was only about 99-99.3 degrees F.
I got a rash on my right arm (but I took the COVID vaccine on my left arm...). Had a rash on April 3rd that was itchy. Went to the pharmacy today April 4th to get an itch cream and the pharmacist told me I was the third or fourth person reporting rash after the vaccination and oriented me to report to CDC. She told me to use hydrocortizone and avoid sun exposure. I used it but still feel itchy.
Red reaction 5 X 6 cm slight tender. No systemic sign onset 2 days after immunization.
He came home and soon after had a high fever. He fell asleep and it was becoming troubling how hard I had to work to wake him up and keep him awake. Once he started to come to he opened his eyes and had glossy red eyes and just looked sick from his body reacting to this shot. He had a deep raspy voice since then as well. I'm curious about the reason my son received a flu shot administered by a volunteer. 1. Without having a signed consent, 2. Without checking his file to see if he had a medical or religious exception, 3. They were using a different child's medical paperwork from a different class. 4. The principal said oh sorry normally I do them all but this year we had a volunteer do them. We will have to change it next year. 5. The majority of the human rights start with medical and I don't know what can be done but we were also charged the fee for it. I am not okay with this in anyway. My thinking is not so much a legality issue, but I have extensive experience and knowledge of the medical world. Patient's rights, laws regarding administration of a vaccine or medication. If you understand what I am so upset about it is just the tip of the iceberg. If my lifestyle is based on religious freedom, or my life choices as a medical provider they put in my son, based on a whole other child's contradictions I have to make sure it does not happen to anyone else. I hope the people who are responsible understand the possibilities for a department investigation into this carelessness of assault physically, spiritually and emotionally. I have to go to the public and we have to demand results from the school district because I entrusted the school to my son's safety and well-being. They violated that then weren't even capable of producing much more than an oops sorry wrong boy. No accountability whatsoever to the thinking and actions that put a volunteer in charge of my son's life and physical health. If we form a more functional use for the flu shot vaccine, I'd consider the use of it. The uncertainty of the first batches made that season for a specific area is primarily a guessing game. I am so sicken by this assault of my poor 6 year old. Assault not only on his little tiny physical body, but worse the mental effect it's creating. I haven't seen him in this zombie like state before. The unknown measure of changes and possible damages to his natural biological and neurological functionality.
This spontaneous case was reported by an other health care professional and describes the occurrence of LYMPHADENOPATHY (Lymph node in upper clavicle) and FATIGUE (Fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 037L20A) for COVID-19 vaccination.  The patient's past medical history included No adverse event. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced LYMPHADENOPATHY (Lymph node in upper clavicle). On 03-Feb-2021, the patient experienced FATIGUE (Fatigue). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) for Prophylaxis, at a dose of 500 mg. On 06-Feb-2021, FATIGUE (Fatigue) had resolved. At the time of the report, LYMPHADENOPATHY (Lymph node in upper clavicle) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: 1.7 centimetre (abnormal) 1.7cm in size and there is blood going through it. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment information included keflex 500 mg.
Approx 1" vesicular eruption around injection site surround by 5-6" bordered red zone. Recommended ice, MOTRIN 600 BID & BACTRIM DS BID x 1 week.
Information has been received from an RN concerning a 5 year old male who on 10/2/97 was vaccinated with varicella virus vaccine live. The child presented to his dermatologist on 12/19/01 with chickenpox. The child's mother reported to the school nurse that the child had "quite a few pox all over". At the time of this report, the outcome of the event was unknown. Additional information has been requested. The nurse also reported that a 6 year old female developed chickenpox following vaccination with varicella virus vaccine live (see WAES0201USA02820).
Pt states that 3weeks after the second vaccination, he noted a slow, irregular heart beat. He was noted on 9/2/21 to be in sinus bradycardia with couplets. Lexiscan - inferior ischemia. Cath: PCI 11/15/2021
patient was administered covid vaccine here in clinic which we thought was the covid bivalent booster, but it was determined that it was not.  Patient received standard covid vaccination.
Flu like symptoms: fever, chills, fatigue, aches, mild headache, stomach discomfort
Quick onset of nausea, abdominal cramping, headache, metallic taste, and itching. Resolved with VISTARIL.
hives the following day and had a Recheck appointment on 11/8/23 with Dr. - dx Allergic urticaria
TOOK THIRD DOSE ON DAY 4; This spontaneous case report was received from a nurse (PVX2019-060) on 08-Jan-2019. The report describes a male consumer who "took third dose on day 4". The consumer was receiving Vivotif for an unknown indication.  It was reported that the consumer took third dose on day 4. The doses were taken on 05-Jan-2019, 07-Jan-2019 and 08-Jan-2019, respectively.  The action taken with Vivotif with respect to the event "took third dose on day 4" was not applicable.  The clinical outcome of the event "took third dose on day 4" was unknown.  Company's Comment: The causality of the event "took third dose on day 4" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took third dose on day 4" was considered as not applicable.
I suffered vertigo 2 weeks later and a related pain in the lower right base of the neck. The pain and vertigo occurred for 2-3 months. I had 4 visits to a vestibular physical therapist to help with symptoms.
received his 1st dose on 15Feb2021, tested positive for COVID-19 on 19Feb2021; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 58-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via unspecified route of administration on 15Feb2021 as a single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported. Patient received his 1st dose on 15Feb2021, tested positive for COVID-19 on 19Feb2021. Patient didn't know he had it and he only had a stuffy nose and felt a little tired on an unknown date in Feb2021 other than that I was ok." On 01Mar2021 test was negative for COVID 19. Patient was off work for half a month, patient was afraid to take the 2nd dose and he heard the 2nd shot was stronger than the 1st". Patient called to get his Dilantin Savings Card, during the conversation, patient explained that he had been vaccinated with the first shot from Pfizer, but he was COVID-19 positive patient after the shot, so now he is afraid of taking the second shot. Patient called to get assistance with Dilantin. During the call the patient stated "he had Covid Yeah and he contracted Covid after he got the Pfizer shot. Patient took the first Pfizer shot and he got and tested positive for Covid." The outcome of the event was unknown.   Information on the Lot/Batch number has been requested.
Child had history of rash 48 hours, swelling of joints, after first set of vaccines.  Therefore vaccines given separately 5-10 minutes after Prevnar given macular paplar rash on right forearm, Given Benadryl and obseevred for additional 30 minutes. No wheexing or tachycardia
Arm is hot to touch & sensitive. The area is red around the immunization site & patient stated it was also had to touch. Symptoms are lessening as time goes on.
14 year old pt received Covid booster dose, currently approved for 16+. Booster was 6 months to the day (would normally be eligible for booster based on timeline). Patient received correct vaccine and dose based on patient's request.
administer expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) in a 45-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Date the vial was initially stored in the refrigerator reported as unknown and the vial did not undergo any temperature excursions. The treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live Non Significant follow up appended